Tech Company M&A Transactions
Acton Pharmaceuticals Acquisition
On 8/30/2013, Acton Pharmaceuticals was acquired by Meda AB. Meda AB said the transaction price was $145 million.
Transaction Overview
Company Name
Acquired By
Announced On
8/30/2013
Transaction Type
M&A
Amount
$145,000,000
M&A Terms
The purchase price for Acton amounts to 135 million USD. In addition, there is a milestone payment of 10 million USD and royalty based milestones.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
225 Cedar Hill St. 115
Marlborough, MA 01752
USA
Marlborough, MA 01752
USA
Phone
Website
Email Address
Overview
Acton is primarily focused on development and commercialization of innovative pharmaceutical products that treat allergic, pulmonary, and other respiratory related diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Simon
Chief Financial Officer
Thomas Phair
Chief Medical Officer
Kenneth Newman
Chief Operating Officer
Daniel Kreisler
VP - Operations
Patrick Noland
Browse more venture capital transactions:
Prev: 8/30/2013: EdCaliber venture capital transaction
Next: 8/30/2013: Insightpool venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs